As of April 2020, a number of treatments and vaccines were in development worldwide to treat COVID-19. This statistic shows the expected early result timelines for the most promising drugs, therapies and vaccines currently in development for COVID-19 (coronavirus) as of April 21, 2020. Early results are expected within the next three months for the mRNA 1273 vaccine by Moderna and NIAID, as well as for Novamax' NVX-CoV2373 vaccine. The development of vaccines is of special interest as only a safe and effective vaccine is expected to stop the spread of the novel coronavirus permanently.
Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020
Name (company, type)
Minimum months
Maximum months
Remdesivir (Gilead Sciences, drug)
0
3
Hydroxychloroquine/chloroquine (drug)
0
3
Actemra/tocilizumab (Roche, drug)
0
3
Kevzara/sarilumab (Sanofi, Regeneron, drug)
0
3
Jakavi/ruxolitinib (Novartic, Incyte, drug)
0
3
mRNA 1273 (Moderna, NIAID, vaccine)
0
3
Convalescent plasma (non-drug therapy)
0
3
Kaletra/lopinavir/ritonavir (AbbVie, drug)
0
3
NKG2D-ACE2 CAR-NK cells (Chongqing Public Health Medical Center, Chongqing Sidemu Biotechnology Technology Co., Ltd., non-drug therapy)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
World Economic Forum. (April 21, 2020). Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020 [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1112264/covid-drugs-therapies-and-vaccines-in-development-by-early-results/
World Economic Forum. "Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020." Chart. April 21, 2020. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1112264/covid-drugs-therapies-and-vaccines-in-development-by-early-results/
World Economic Forum. (2020). Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1112264/covid-drugs-therapies-and-vaccines-in-development-by-early-results/
World Economic Forum. "Early Result Timelines for Most Promising Covid-19 Treatments and Vaccines in Development as of April 21, 2020." Statista, Statista Inc., 21 Apr 2020, https://www.statista.com/statistics/1112264/covid-drugs-therapies-and-vaccines-in-development-by-early-results/
World Economic Forum, Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020 Statista, https://www.statista.com/statistics/1112264/covid-drugs-therapies-and-vaccines-in-development-by-early-results/ (last visited December 21, 2024)
Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020 [Graph], World Economic Forum, April 21, 2020. [Online]. Available: https://www.statista.com/statistics/1112264/covid-drugs-therapies-and-vaccines-in-development-by-early-results/
